ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 46 Questions
Question 1 of 5
A patient is receiving doxorubicin as part of treatment for ovarian cancer. Which of these is a possible adverse effect of doxorubicin?
Correct Answer: A
Rationale: Decreased cardiac output related to the adverse effect of cardiotoxicity is a possible adverse effect related to doxorubicin because adverse effects of doxorubicin include liver and cardiovascular toxicities.
Question 2 of 5
When giving cisplatin, the nurse is aware that adverse effect of this drug is which condition?
Correct Answer: B
Rationale: Cisplatin may cause nephrotoxicity, and the patient's renal function must be monitored closely while on this drug. Ensuring hydration will help to prevent nephrotoxicity.
Question 3 of 5
The nurse is teaching a class about the various chemotherapy drugs. Which of these statements explains why alkylating drugs are also called 'cell cycle-nonspecific drugs'?
Correct Answer: B
Rationale: Cell cycle-nonspecific drugs kill cancer cells during any phase of the growth cycle, whereas cell cycle-specific drugs kill cancer cells during specific phases of the cell growth cycle.
Question 4 of 5
What is the nurse's priority action if extravasation of an antineoplastic drug occurs during intravenous (IV) administration?
Correct Answer: C
Rationale: If extravasation is suspected, administration of the drug must be stopped immediately but the IV catheter left in place and the appropriate antidote instilled through the existing IV tube, after which the needle may be removed.
Question 5 of 5
A patient is receiving a third session of chemotherapy with daunorubicin. The nurse will assess the patient for which signs of a potential severe toxic effect of this drug?
Correct Answer: C
Rationale: Cardiac toxicity may occur, so frequent checking of heart and breath sounds is necessary and daily weights need to be recorded (with reporting of an increase of 2 pounds or more in 24 hours or 5 pounds or more in 1 week).